Oxcarbazepine primarily works by blocking voltage-gated sodium channels. This reduces the excessive neuronal firing characteristic of epileptic seizures.
Specifically, it binds to the inactivated state of these channels, prolonging their inactivation period. This significantly limits the propagation of seizure activity across brain regions.
Beyond sodium channel blockade, oxcarbazepine also influences other mechanisms. It modulates the release of excitatory neurotransmitters like glutamate, decreasing neuronal excitation.
Furthermore, it enhances the activity of GABA, an inhibitory neurotransmitter, further dampening neuronal excitability and preventing seizure spread.
This multifaceted action contributes to its efficacy in various epilepsy syndromes, including partial seizures and generalized tonic-clonic seizures. Its use extends beyond epilepsy; it’s also prescribed for certain types of trigeminal neuralgia due to its ability to reduce neuronal hyperexcitability in affected nerve pathways.
The precise contribution of each mechanism varies depending on the specific seizure type and individual patient factors. However, the combined effect of sodium channel blockade, glutamate modulation, and GABA enhancement produces a powerful anticonvulsant effect.
